Illumina Financial Statements (ILMN)
|
|
|
|
Report date
|
|
|
18.02.2022 |
03.07.2022 |
01.01.2023 |
17.02.2023 |
16.02.2024 |
|
06.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 526 |
|
4 584 |
4 584 |
4 504 |
|
4 348 |
|
Operating Income, bln rub |
|
|
-123.0 |
|
-4 179 |
-4 179 |
-1 069 |
|
1 907 |
|
EBITDA, bln rub |
? |
|
747.0 |
|
-4 336 |
-3 916 |
-608.0 |
|
-267.0 |
|
Net profit, bln rub |
? |
|
762.0 |
|
-4 404 |
-4 404 |
-1 161 |
|
-704.0 |
|
|
OCF, bln rub |
? |
|
545.0 |
|
392.0 |
392.0 |
478.0 |
|
789.0 |
|
CAPEX, bln rub |
? |
|
208.0 |
|
286.0 |
466.0 |
195.0 |
|
131.0 |
|
FCF, bln rub |
? |
|
337.0 |
|
106.0 |
-74.0 |
282.0 |
|
658.0 |
|
Dividend payout, bln rub
|
|
|
0.000 |
|
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
|
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
3 277 |
|
5 539 |
2 618 |
3 813 |
|
1 947 |
|
Cost of production, bln rub |
|
|
1 372 |
|
1 612 |
1 612 |
1 760 |
|
1 470 |
|
R&D, bln rub |
|
|
1 185 |
|
1 321 |
1 321 |
1 354 |
|
1 169 |
|
Interest expenses, bln rub |
|
|
61.0 |
|
0.000 |
26.0 |
77.0 |
|
74.0 |
|
|
Assets, bln rub |
|
|
15 217 |
15 448 |
12 252 |
12 252 |
10 111 |
|
6 014 |
|
Net Assets, bln rub |
? |
|
10 740 |
10 444 |
6 599 |
6 599 |
5 745 |
|
2 125 |
|
Debt, bln rub |
|
|
2 469 |
1 521 |
1 492 |
3 479 |
2 262 |
|
2 674 |
|
Cash, bln rub |
|
|
1 339 |
1 327 |
26.0 |
2 037 |
1 054 |
|
939.0 |
|
Net debt, bln rub |
|
|
1 130 |
194.0 |
1 466 |
1 442 |
1 208 |
|
1 735 |
|
|
Ordinary share price, rub |
|
|
369.7 |
191.0 |
202.2 |
196.5 |
135.3 |
|
112.8 |
|
Number of ordinary shares, mln |
|
|
150.0 |
|
157.0 |
157.0 |
158.0 |
|
159.0 |
|
|
Market cap, bln rub |
|
|
55 458 |
0 |
31 745 |
30 851 |
21 381 |
|
17 929 |
|
EV, bln rub |
? |
|
56 588 |
194 |
33 211 |
32 293 |
22 589 |
|
19 664 |
|
Book value, bln rub |
|
|
377 |
84 |
75 |
75 |
207 |
|
707 |
|
|
EPS, rub |
? |
|
5.08 |
|
-28.1 |
-28.1 |
-7.35 |
|
-4.43 |
|
FCF/share, rub |
|
|
2.25 |
|
0.68 |
-0.47 |
1.78 |
|
4.14 |
|
BV/share, rub |
|
|
2.51 |
|
0.48 |
0.48 |
1.31 |
|
4.45 |
|
|
EBITDA margin, % |
? |
|
16.5% |
|
-94.6% |
-85.4% |
-13.5% |
|
-6.14% |
|
Net margin, % |
? |
|
16.8% |
|
-96.1% |
-96.1% |
-25.8% |
|
-16.2% |
|
FCF yield, % |
? |
|
0.61% |
0.00% |
0.33% |
-0.24% |
1.32% |
|
3.67% |
|
ROE, % |
? |
|
7.09% |
0.00% |
-66.7% |
-66.7% |
-20.2% |
|
-33.1% |
|
ROA, % |
? |
|
5.01% |
0.00% |
-35.9% |
-35.9% |
-11.5% |
|
-11.7% |
|
|
P/E |
? |
|
72.8 |
|
-7.21 |
-7.01 |
-18.4 |
|
-25.5 |
|
P/FCF |
|
|
164.6 |
|
299.5 |
-416.9 |
75.8 |
|
27.2 |
|
P/S |
? |
|
12.3 |
|
6.93 |
6.73 |
4.75 |
|
4.12 |
|
P/BV |
? |
|
147.1 |
0.00 |
423.3 |
411.3 |
103.3 |
|
25.4 |
|
EV/EBITDA |
? |
|
75.8 |
|
-7.66 |
-8.25 |
-37.2 |
|
-73.6 |
|
Debt/EBITDA |
|
|
1.51 |
|
-0.34 |
-0.37 |
-1.99 |
|
-6.50 |
|
|
R&D/CAPEX, % |
|
|
569.7% |
|
461.9% |
283.5% |
694.4% |
|
892.4% |
|
|
CAPEX/Revenue, % |
|
|
4.60% |
|
6.24% |
10.2% |
4.33% |
|
3.01% |
|
| Illumina shareholders |
